FDA Testing Regs Should Be Loosened, Allow More Human Models – Petition
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug sponsors need less expensive options beyond traditional animal models to fulfill preclinical data requirements, coalition of 14 groups and companies says.